Literature DB >> 12110030

Cardiovascular disease in pediatric chronic dialysis patients.

Blanche M Chavers1, Shuling Li, Allan J Collins, Charles A Herzog.   

Abstract

BACKGROUND: Little information is available regarding cardiac morbidity and mortality in children with end-stage renal disease. We sought to determine the incidence of cardiac morbidity and mortality in pediatric chronic dialysis patients.
METHODS: Medicare incident pediatric (0 to 19 years) dialysis patients from 1991 to 1996 were identified from the United States Renal Data System. Study endpoints included development of arrhythmia, valvular heart disease, cardiomyopathy, or cardiac arrest, all causes of death, and cardiac-related death. Statistical analyses were performed using the Poisson regression model and chi-square test.
RESULTS: A total of 1454 children were eligible for inclusion, 452 (31.1%) of whom developed a cardiac-related event. Arrhythmia was the most common event (19.6%) compared with valvular disease (11.7%), cardiomyopathy (9.6%), and cardiac arrest (3%). Arrhythmia and valvular heart disease incidence were increased in 15- to 19-year-olds (P < 0.0001 for both), females (P = 0.004, P = 0.03) and blacks (P < 0.0001, P = 0.002). Cardiomyopathy incidence was increased in blacks (P = 0.001) and tended to be increased in females (P = 0.053). The adjusted annual cardiomyopathy rate during the first 3 years increased between 1991 and 1996 (P = 0.003). Death occurred in 107 patients, and 41 (38%) were cardiac deaths.
CONCLUSIONS: Cardiovascular disease is a significant cause of morbidity and mortality in pediatric chronic dialysis patients. Cardiomyopathy incidence is increasing. Black, female, and adolescent children have increased risk for cardiovascular disease.

Entities:  

Mesh:

Year:  2002        PMID: 12110030     DOI: 10.1046/j.1523-1755.2002.00472.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  68 in total

1.  Vitamin D status of children receiving chronic dialysis.

Authors:  Basema I Dibas; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2012-06-03       Impact factor: 3.714

Review 2.  Cardiovascular complications in pediatric end-stage renal disease.

Authors:  Rulan S Parekh; Samuel S Gidding
Journal:  Pediatr Nephrol       Date:  2004-12-15       Impact factor: 3.714

3.  Cardiac geometry in children receiving chronic peritoneal dialysis: findings from the International Pediatric Peritoneal Dialysis Network (IPPN) registry.

Authors:  Sevcan A Bakkaloglu; Dagmara Borzych; Il Soo Ha; Erkin Serdaroglu; Rainer Büscher; Paulina Salas; Hiren Patel; Dorota Drozdz; Karel Vondrak; Andreia Watanabe; Jorge Villagra; Onder Yavascan; Maria Valenzuela; Deborah Gipson; K H Ng; Bradley A Warady; Franz Schaefer
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

4.  Frequent hemodialysis with NxStage system in pediatric patients receiving maintenance hemodialysis.

Authors:  Stuart L Goldstein; Douglas M Silverstein; Jocelyn C Leung; Daniel I Feig; Beth Soletsky; Cathy Knight; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2007-11-08       Impact factor: 3.714

5.  Maps of Ventricular Activation Time (VAT) Differences in Children on Peritoneal Dialysis - a Pilot Study.

Authors:  Krystyna Laszki-Szcząchor; Dorota Polak-Jonkisz; Danuta Zwolińska; Ewa Salomon; Henryk Filipowski; Małgorzata Sobieszczańska
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

6.  Evaluation of aortic stiffness in children with chronic renal failure.

Authors:  Ali Rahmi Bakiler; Onder Yavascan; Nilgun Harputluoglu; Orhan Deniz Kara; Nejat Aksu
Journal:  Pediatr Nephrol       Date:  2007-08-21       Impact factor: 3.714

7.  One-year mortality rates in US children with end-stage renal disease.

Authors:  Blanche M Chavers; Julia T Molony; Craig A Solid; Michelle N Rheault; Allan J Collins
Journal:  Am J Nephrol       Date:  2015-03-07       Impact factor: 3.754

Review 8.  Long-term outcome of chronic dialysis in children.

Authors:  Rukshana Shroff; Sarah Ledermann
Journal:  Pediatr Nephrol       Date:  2008-01-23       Impact factor: 3.714

Review 9.  The osteocyte in CKD: new concepts regarding the role of FGF23 in mineral metabolism and systemic complications.

Authors:  Katherine Wesseling-Perry; Harald Jüppner
Journal:  Bone       Date:  2012-10-16       Impact factor: 4.398

Review 10.  Treatment of hypertension in children and adolescents.

Authors:  Marc B Lande; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2007-08-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.